GEN Exclusives

More »

GEN News Highlights

More »
Sep 6, 2010

Researchers Determine Proinflammatory Enzyme’s Role in Limiting Neutrophil Inflammation in the Lung

  • Scientists have deciphered how leukotriene A4 hydrolase (LTA4H) acts as a proinflammatory enzyme. The research may also provide new clues to why cigarette smoke is a significant risk factor for developing diseases of the lung such as chronic bronchitis and emphysema, according to the researchers from Imperial College London and the University of Alabama at Birmingham.

    The study is published in a paper titled “A Critical Role for LTA4H in Limiting Chronic Pulmonary Neutrophilic Inflammation,” appearing in the September 2 issue of Science.

    PGP is a biomarker for chronic obstructive pulmonary disease (COPD) and is implicated in neutrophil persistence in the lung. The enzymes released by neutrophils can cause particular damage in the lung, where they can attack collagen, selectively cutting out a molecular fragment known as PGP. This fragment in turn recruits more neutrophils, potentially leading to a vicious circle of damage.

    The investigators found that in acute neutrophil-driven inflammation, LTA4H, which generates the inflammatory mediator leukotriene B4 (LTB4), degraded PGP and thus facilitated the resolution of inflammation. In contrast, cigarette smoke, another major risk factor for COPD, selectively inhibited LTA4H aminopeptidase activity, which led to the accumulation of PGP and neutrophils.

    The researchers believe that the research may have implications for the development of new drugs aimed at treating acute and inflammatory diseases. However, as well as working to reduce inflammation, LTA4H more commonly works to promote inflammation. Therefore, drugs aimed at inhibiting the pro-inflammatory activity of LTA4H could result in preventing degradation of PGP, causing potential lung damage, they caution.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Ill Patients Access to Experimental Medicines?

More »